MEGAN NAGEL: Open Payments
NPI 1134561012 · COFFEYVILLE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$424 in 15 payments from 8 companies in 2025. Trend: 2023 $51 · 2024 $28 · 2025 $424
Food & beverage: $424
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 1 | $125 |
| ABBVIE INC. | 4 | $107 |
| E.R. Squibb & Sons, L.L.C. | 3 | $64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $17 |
| Dexcom, Inc. | 1 | $16 |
Products named: DOVATO, COBENFY, UBRELVY, MAVYRET, CAPLYTA, VOQUEZNA, REXULTI, Wegovy.
Industry payments across KS — which companies pay providers there.
